German VCs stake distinguished prof’s anti-cancer ace
By GREGORY ZELLER // German venture capitalists have locked and loaded a Stony Brook University spinoff’s next-generation weapon against malignant tumors. Munich-based VC firm TVM Capital Life Science – whose…